<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
---
JONES PHARMA INCORPORATED
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $.04 PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
480236 10 8
- --------------------------------------------------------------------------------
(CUSIP Number)
CHARLES E. H. LUEDDE, ESQ.
10 SOUTH BROADWAY, SUITE 2000, ST. LOUIS, MISSOURI 63102 (314) 241-9090
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
APRIL 3, 2000
- -------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), (f) or (g), check the following
box [ ].
NOTE. Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for
other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
- --------------------------------------------------------------------------------
CUSIP No. 480236 10 8 13D Page 2 of 4 Pages
- --------------------------------------------------------------------------------
<TABLE>
<S><C>
- --------------------------------------------------------------------------------------------------------------------
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above Persons (entities only)
DENNIS M. JONES; JUDITH A. JONES
- ---------- ---------------------------------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) |X|
(b) |_|
- ---------- ---------------------------------------------------------------------------------------------------------
3 SEC Use Only
- ---------- ---------------------------------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
OO
- ---------- ---------------------------------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) |_|
- ---------- ----------------------------------------------------------------------------------------------------------
6 Citizenship or Place of Organization
UNITED STATES
- ---------- ---------------------------------------------------------------------------------------------------------
Number of 7 Sole Voting Power
Shares 7,676,599
------------ -----------------------------------------------------------------------------------
Beneficially 8 Shared Voting Power
Owned by -0-
------------ -----------------------------------------------------------------------------------
Each 9 Sole Dispositive Power
Reporting 7,676,599
------------ -----------------------------------------------------------------------------------
10 Shared Dispositive Power
Person With
-0-
- ---------- ---------------------------------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
7,676,599
- ---------- ---------------------------------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) |_|
- ---------- ---------------------------------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
11.51%
- ---------- ---------------------------------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
IN
- ---------- ---------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE> 3
- --------------------------------------------------------------------------------
CUSIP No. 480236 10 8 13D Page 3 of 4 Pages
- --------------------------------------------------------------------------------
AMENDMENT NO. 1 TO SCHEDULE 13D
Dennis M. Jones and Judith A. Jones reported the acquisition of shares
of Common Stock, par value $.04 per share ("Stock"), of JONES PHARMA
INCORPORATED, a Delaware corporation (the "Issuer"), in an initial filing of
this Schedule 13D on April 20, 1999. The Cover Page, Page 2 and Items 5 and 7
are hereby amended as follows. All other items are unchanged from the initial
filing.
ITEM 5. Interest in Securities of the Issuer.
(a,b) As of March 1, 2000, Dennis M. Jones (and/or his revocable trust) is
deemed to own beneficially an aggregate of 5,136,492 shares of Common Stock of
the Issuer, excluding shares held by Judith A. Jones, representing 7.7% of the
Issuer's Common Stock. Such holdings include 972,000 shares currently under
option to Mr. Jones from the Issuer which are presently or will become
exercisable on or prior to June 1, 2000. Mr. Jones has sole voting and
dispositive power with respect to such shares.
As of March 1, 2000, Judith A. Jones (and/or her revocable trust) is
deemed to own beneficially an aggregate of 2,540,107 shares of the Common Stock
of the Issuer, excluding shares held by Dennis M. Jones, representing 3.81% of
the Issuer's Common Stock. Such holdings include 243,000 shares currently under
option to Mrs. Jones from the Issuer which are presently or will become
exercisable on or prior to June 1, 2000. Mrs. Jones has sole voting and
dispositive power with respect to such shares.
(c) Mrs. Jones has not had any transactions in the Issuer's Common Stock within
the 60 days preceding the filing of this Amendment No. 1 to Schedule 13D.
Including disposition by gifts of: (i) 18,000 shares on February 11,
2000; and (ii) 3,000 shares on February 23, 2000, Mr. Jones (and/or his
revocable trust) has had the following sales of the Issuer's Common Stock within
the 60 days preceding the filing of this Amendment No. 1 to Schedule 13D:
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------
NUMBER NET PRICE
SALES IN THE NAME OF DATE OF SHARES PER SHARE TRANSACTIONS MADE THROUGH
------------------------------ ---------- ------------ -------------- --------------------------------
<S> <C> <C> <C> <C>
Dennis M. Jones 2/25/00 206,250* $47.25 Salomon Smith Barney
------------------------------ ---------- ------------ -------------- --------------------------------
Dennis M. Jones 2/28/00 105,000* $47.32 Salomon Smith Barney
------------------------------ ---------- ------------ -------------- --------------------------------
Dennis M. Jones 2/29/00 121,800* $47.78 Salomon Smith Barney
------------------------------ ---------- ------------ -------------- --------------------------------
Dennis M. Jones 3/1/00 61,800* $47.58 Salomon Smith Barney
------------------------------ ---------- ------------ -------------- --------------------------------
Dennis M. Jones 3/2/00 5,500 $46.10 Salomon Smith Barney
------------------------------ ---------- ------------ -------------- --------------------------------
Dennis M. Jones 3/3/00 150,000 $44.66 Salomon Smith Barney
------------------------------ ---------- ------------ -------------- --------------------------------
</TABLE>
* Adjusted for two (2) three-for-two stock splits effective August 6,
1999 and March 1, 2000.
(d)(e) Not applicable.
ITEM 7. Material to be Filed as Exhibits.
---------------------------------
Exhibit 1: Rule 13d-1(k)(1) Joint Filing Agreement.
<PAGE> 4
- -------------------------------------------------------------------------------
CUSIP No. 480236108 13D Page 4 of 4 Pages
- -------------------------------------------------------------------------------
After reasonable inquiry, and to the best of the undersigneds'
knowledge and belief, the undersigned certify that the information set forth in
this statement is true, complete and correct.
/s/ Dennis M. Jones
-------------------------------------------
Dennis M. Jones
Individually and as Trustee of the Dennis M. Jones
Amended and Restated Revocable Trust dated
March 16, 1993
Date: April 3, 2000
/s/ Judith A. Jones
-------------------------------------------
Judith A. Jones
Individually and as Trustee of the Judith A. Jones
Amended and Restated Revocable Trust dated June
8, 1993
Date: April 3, 2000
<PAGE> 1
Exhibit 1 to Amendment No. 1 to Schedule 13D
RULE 13d-1(k)(1) JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act
of 1934, as amended, the undersigned agree that for purposes of reports on
Schedule 13D or Schedule 13G relating to the undersigneds' holdings of shares of
the Common Stock, par value $.04 per share, of JONES PHARMA INCORPORATED, such
filings shall be effected by a single joint statement.
IN WITNESS WHEREOF, this Joint Filing Agreement has been executed this
3rd day of April, 2000, by the undersigned.
/s/ Dennis M. Jones
-------------------------------------------
Dennis M. Jones
Individually and as Trustee of the Dennis M. Jones
Amended and Restated Revocable Trust dated
March 16, 1993
/s/ Judith A. Jones
-------------------------------------------
Judith A. Jones
Individually and as Trustee of the Judith A. Jones
Amended and Restated Revocable Trust dated June
8, 1993
